COVID-19 vaccines present favorable immunogenicity and efficacy in individuals dwelling with HIV

COVID-19 vaccines present favorable immunogenicity and efficacy in individuals dwelling with HIV

In a latest examine revealed within the Worldwide Journal of Infectious Ailments, researchers assessed the efficacy of coronavirus illness 2019 (COVID-19) vaccines in individuals dwelling with human immunodeficiency virus (HIV).

COVID-19 vaccines present favorable immunogenicity and efficacy in individuals dwelling with HIVResearch: Immunogenicity and efficacy of COVID-19 vaccines in individuals dwelling with HIV: a scientific evaluate and meta-analysis. Picture Credit score: Corona Borealis Studio / Shutterstock

The morbidity, mortality, issues, and vital financial disruption attributable to COVID-19 have sped up the invention of extremely efficient vaccines to beforehand unheard-of ranges. There may be, nonetheless, a scarcity of knowledge on the effectiveness and security of vaccines within the individuals dwelling with HIV (PLWH) teams since vaccine trials didn’t publish knowledge regarding individuals dwelling with HIV. These people are of explicit curiosity for the reason that authentic sickness or any concomitant remedies could have suppressed or overactivated their immune techniques. As well as, since viral shedding and an infection have been famous to be extra extreme and protracted in PLWH, knowledge on this inhabitants are urgently wanted.

In regards to the examine

Within the current examine, researchers in contrast the immunogenicity and effectiveness of COVID-19 vaccinations in PLWH with wholesome people.

The staff electronically searched the Cochrane Library, PubMed/Medline, and EMBASE for revealed articles. First, the analysis papers had been screened by title and summary, adopted by screening the article’s full textual content. Then, two researchers examined every title, summary, and whole textual content individually.

The staff performed a meta-analysis of potential research that fulfilled the next necessities: sufferers who obtained a COVID-19 vaccine of any model and sort; people dwelling with HIV/acquired immunodeficiency syndrome (AIDS); articles that included and documented knowledge associated to a management group comprising people who aren’t HIV-infected; and research reporting a minimal of 1 case of both seroconversion or serological titer values after COVID-19 vaccination.

The staff carried out a publish hoc modification to incorporate articles that reported knowledge associated to potential observational; qualitative evaluation, or experimental research involving human topics, all of whom had been COVID-19-vaccinated with any vaccine model and sort; research involving people dwelling with HIV/AIDS, and research that revealed seroconversion charges of PLWH both with or and not using a management group.

The setting of the examine, main and secondary outcomes, pattern measurement, inclusion and exclusion standards, dropout and non-response charges, and examine design had been all included within the knowledge on examine traits. Age, intercourse, and medical historical past, together with immunosuppressive remedy historical past, had been all included within the participant data. Eight vaccine varieties and types, a dosage schedule, the variety of individuals who obtained every type and model of vaccination, and the median or imply interval between doses had been among the many data associated to the intervention. Assay sort, antibody examined, measurement technique, pattern assortment intervals, and the variety of measurements had been among the many outcome-related variables. Seroconversion following the primary and second doses of the COVID-19 vaccine was the first consequence of curiosity.


The full variety of research included within the meta-analysis of seroconversion charges was 22. Ten of the 22 research employed messenger ribonucleic acid (mRNA) vaccines, together with BNT162b2 and mRNA-1273; six used inactivated vaccines, together with CoronaVac and BBIBP-CorV; 5 used viral vector vaccines, together with AZD1222 and Ad26.CoV2.S; and one used recombinant spike protein nanoparticle vaccines co-formulated with a saponin-based adjuvant, Matrix-M. Among the many viral vector vaccines, 4 research used AZD1222, together with three the place it served as the one vaccine, whereas Ad26.COV2.S was solely utilized in one.

In comparison with wholesome controls, seroconversion was documented in PLWH in seven investigations following the primary dose of the vaccination. The seroconversion charge between wholesome controls and PLWH was comparable. After receiving a second dose of the vaccine, seroconversion charges among the many PLWH had been decrease than these of wholesome controls in 20 research, together with 2,068 PLWH and 4,454 wholesome controls. After receiving a second dose of the vaccine, people’ antibody titers didn’t seem like considerably altered or decreased.

After the primary and second doses, subgroup analyses had been carried out for trials together with solely mRNA and non-mRNA vaccines. The results of mRNA vaccinations and non-mRNA vaccines on seroconversion weren’t noticeably completely different after the preliminary dosage. After the second dose, there have been no discernible variations within the results of the mRNA and non-mRNA vaccines on seroconversion.

Total, the examine findings confirmed that in PLWH, COVID-19 vaccinations exhibited optimistic immunogenicity and effectiveness. Regardless that the seroconversion post-second vaccination was marginally decrease in PLWH in comparison with wholesome people, a second dosage is constantly related to improved seroconversion. Further measures, comparable to a follow-up dose of the mRNA COVID-19 vaccine, might improve these people’ seroprotection.

Journal reference:

  • Juntao Yin, Yangyang Chen, Yang Li, Chaoyang Wang, Xingwang Zhang, Immunogenicity and efficacy of COVID-19 vaccines in individuals dwelling with HIV: a scientific evaluate and meta-analysis, Worldwide Journal of Infectious Ailments, 2022, ISSN 1201-9712, DOI:,